Table 1 Baseline characteristics of 84 patients with NTM lung disease and 47 non-NTM BE patients
NTM lung disease patients | Non-NTM BE patients | P value | |
|---|---|---|---|
(N = 84) | (N = 47) | ||
Age (year), median (IQR) | 67 (57,75) | 64 (58,70) | 0.16 |
Female | 54 (64.3%) | 29 (61.7%) | 0.85 |
Never smoker | 57 (67.9%) | 35 (74.5%) | 0.55 |
BCG scar | 170 (83.3%) | 40 (85.1%) | 1.00 |
Past medical history | |||
TB | 23 (27.4%) | 20 (42.6%) | 0.08 |
Measles | 15 (17.9%) | 15 (31.9%) | 0.08 |
Pertussis | 4 (4.8%) | 4 (8.5%) | 0.46 |
Comorbidities | |||
aSinusitis | 26 (31.0%) | 15 (31.9%) | 1.00 |
COPD | 17 (20.2%) | 17 (37.0%) | 0.06 |
Asthma | 3 (3.6%) | 1 (2.2%) | 1.00 |
Gastroesophageal reflux disease | 15 (17.9%) | 11 (23.4%) | 0.50 |
Diabetes mellitus | 8 (9.5%) | 1 (2.1%) | 0.16 |
Rheumatoid arthritis | 9 (10.7%) | 2 (4.3%) | 0.33 |
Cancer | 18 (21.4%) | 3 (6.4%) | 0.03 |
Symptoms | |||
Cough | 25 (29.8%) | 16 (34.0%) | 0.70 |
bDyspnea | 6 (7.1%) | 6 (12.8%) | 0.40 |
Sputum | 39 (46.4%) | 29 (61.7%) | 0.10 |
Fever | 16 (19.0%) | 12 (25.5%) | 0.38 |
Hemoptysis | 19 (22.9%) | 17 (36.2%) | 0.15 |
Post nasal drip | 25 (29.8%) | 20 (42.6%) | 0.18 |
Weight loss | 13 (15.5%) | 2 (4.3%) | 0.08 |